Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Study of GSK Biologicals' Human Papillomavirus Vaccine (GSK580299) in Female American and Canadian Subjects Who Had Received Control Vaccine in Study 580299/008

NCT00799825 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00799825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00799825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine (GSK580299) in Female American and Canadian Subjects Who Had Received Control Vaccine in Study 580299/008
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
January 1, 2009
Completion date
August 2, 2012
Enrollment
346 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

infections, papillomavirus